Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "drug"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.4/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the annotations (read-only, idempotent), the description discloses important behaviors: ambiguous name matches return `figi_candidates`, unresolved identifiers are listed under `unresolved`, enrichment degrades gracefully when GLEIF/OpenFIGI are down, and identifier provenance is labelled per source. This gives the agent a strong model of edge-case behavior.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with examples and a clear usage directive, but the 'company' branch is a single sprawling parenthetical that packs many distinct behaviors into one hard-to-parse sentence. It would be more concise and scannable with bullets or shorter sentences.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, so the description carries the burden of explaining return behavior. It covers return fields for both company and drug types, ambiguity handling, unresolved identifiers, input acceptance, and degradation behavior. An agent has enough context to invoke the tool correctly across the main scenarios.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description still adds substantial value: it provides concrete value formats ('AAPL', '0000320193'), explains ISIN-to-LEI mapping, and warns against passing full noun phrases like 'NEW YORK ST DORM AUTH revenue bonds.' This goes well beyond the schema's simple field descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool resolves user-spoken names into canonical/official identifiers and enumerates supported types ('company', 'drug') with concrete examples. It does not explicitly distinguish itself from siblings like entity_profile, but the 'other tools require as input' phrasing establishes its role as a lookup utility.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit trigger: 'Use FIRST whenever you have a name but need an ID.' It also specifies when to use the company vs drug branches. However, it does not state when not to use this tool or name alternative tools for richer entity research.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.4/5.0
Disambiguation2/5

Many tools have overlapping purposes, such as the three ask_pipeworx variants, the memory tools (remember/recall/forget), and the subscription management tools. Additionally, the D&D tools are mixed with a large set of unrelated tools, causing confusion between domains.

Naming Consistency2/5

Naming conventions are inconsistent: some tools follow verb_noun pattern (e.g., get_class, list_spells), while others use descriptive noun phrases (e.g., ai_visibility_check, polymarket_arbitrage). There is no clear, predictable pattern across the set.

Tool Count2/5

With 35 tools, the count is high for a server ostensibly focused on D&D 5e. The inclusion of many unrelated tools from the Pipeworx ecosystem makes the set feel bloated and unfocused for the intended domain.

Completeness1/5

For the D&D 5e domain, only 4 tools exist (get_class, get_monster, get_spell, list_spells), which is severely incomplete. The remaining tools cover other domains, but they do not serve the server's primary purpose, leaving obvious gaps in functionality.